The American Telemedicine Association's Nexus 2025 unites leaders from across the digital health ecosystem to explore the future of care delivery. With participants ranging from health system executives and clinicians to government stakeholders and innovators, the event fosters collaboration and showcases the cutting-edge strategies shaping the next era of digital care.
Foley & Lardner is proud to continue our long-standing support of ATA and our continuing sponsorship of ATA Nexus. Our team will be onsite sharing critical insights at the intersection of law, innovation, and health care — from telehealth regulations and data privacy to AI governance and digital therapeutics. Foley's robust presence includes presentations and legal resources designed to help organizations navigate the evolving landscape of digital health.
Join us as we contribute to the national conversation on digital care delivery and provide practical guidance for building scalable, compliant, and patient-centered virtual care models. Take a look at our presentations, below, and reach out to any one of our presenters for more information or to talk.
Foley presenters: (in order of appearance)
The Business of Telehealth: The Biggest Legal Issues You Need to Understand
(Deep Dive Session)
Saturday, May 3, beginning @ 3 pm CT
- Host: Nathaniel Lacktman, Chair of Foley's Telemedicine & Digital Health Team and member of ATA's Board of Directors
- Jennifer Hennessy, Partner
- Presentation: Data Privacy Considerations for your Digital Strategy
- Additional Resource: U.S. State Comprehensive Consumer Data Privacy Law Comparison
- Nathan A. Beaver, Partner and Co-chair of
Foley's Medical Device Area of Focus, and Marika Miller, Associate
- Presentation: DEA Telemedicine Prescribing: Special Registrations, Waivers, Buprenorphine, and What to Expect
- Additional Resources:
- New DEA Rule Extends Controlled Substance Telemedicine Prescribing Flexibilities One More Year
- DEA Unveils Long-Overdue Special Registration for Telemedicine in Proposed Rule
- DEA Tightens Buprenorphine Telemedicine Prescribing Rules
- DEA Delays Final Buprenorphine Rule
- DEA Buprenorphine Rule Delayed to December 31,
2025
- Jacqueline Acosta, Special Counsel, and Olivia Dresevic, Associate
- Additional Resource: Asynchronous Telemedicine by the Numbers – 2025
- Hannah Zaitlin, Partner, and Evan Hellman, Senior Counsel
- David Sanders, Partner, and Larry Perlman, MD, Partner
- T.J. Ferrante, Partner and Vice Chair of
Foley's Health Care Practice Group
- Additional Resource: Digital Therapeutics
- Kyle Faget, Partner and Co-chair of Foley's
Medical Device Area of Focus, and Caitlin Otis, Associate
- Additional Resource: Telehealth Companies and Social Media Influencers May Face New FDA Laws
Saturday, May 3, beginning @ 3 pm CT
Foley presenters: (in order of appearance)
- Michaela Wiese, Associate
- Presentation: Unlocking AI's Potential in Health Care and Virtual Care: Governance, Implementation & Real-World Impact
- Aaron Maguregui, Partner and Co-chair of
Foley's Data Analytics/Intelligence Area of Focus
- Presentation: Navigating AI Regulatory Compliance in Health Care: Ethics, Approvals, and Legal Challenges
Sunday, May 4, beginning @ 3 pm CT
Foley presenters: (in order of appearance)
- Nathaniel Lacktman, Partner and Chair of
Foley's Telemedicine & Digital Health Team and member of
ATA's Board of Directors
- Presentation: Navigating Telehealth Compliance: Adapting to an Ever-Shifting Policy Landscape
Monday, May 5, beginning @ 3 pm CT
Foley presenters: (in order of appearance)
- Nathan Beaver, Partner and Co-chair of
Foley's Medical Device Area of Focus
- Presentation: Remote Prescribing Redefined: Safeguarding Access & Patient Safety